| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |